UMIN000047536
Biochemical adaptive radiation therapy based on prostate-specific antigen response in salvage radiation therapy for postoperative biochemical failure of prostate cancer.
Kamagaya General Hospital·University Hospital Medical Information Network·otherRecruiting
Study focus
- Disease/Condition
- Prostate cancer
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Kamagaya General Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- May 17, 2022
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of prostateHyperplasia of prostateDisorder of prostate, unspecifiedOther disorders of prostateCarcinoma in situ: Prostate
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000047536
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000047536 through Pure Global AI's free database. This phase not specified trial is sponsored by Kamagaya General Hospital and is currently Recruiting. The study focuses on Prostate cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.